Literature DB >> 22692914

Brain structural and functional recovery following initiation of combination antiretroviral therapy.

James T Becker1, Pablo Cuesta, Melissa Fabrizio, Gustavo Sudre, Emanuel N Vergis, Antoine Douaihy, Ricardo Bajo, Allie Schubert, Oscar L Lopez, Lauri Parkkonen, Fernando Maestu, Anto Bagic.   

Abstract

NeuroAIDS persists in the era of combination antiretroviral therapies. We describe here the recovery of brain structure and function following 6 months of therapy in a treatment-naive patient presenting with HIV-associated dementia. The patient's neuropsychological test performance improved and his total brain volume increased by more than 5 %. Neuronal functional connectivity measured by magnetoencephalography changed from a pattern identical to that observed in other HIV-infected individuals to one that was indistinguishable from that of uninfected control subjects. These data suggest that at least some of the effects of HIV on the brain can be fully reversed with treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692914      PMCID: PMC3459170          DOI: 10.1007/s13365-012-0115-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  11 in total

1.  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  G J Dore; P K Correll; Y Li; J M Kaldor; D A Cooper; B J Brew
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

2.  Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.

Authors:  James T Becker; Melissa Fabrizio; Gustavo Sudre; Anna Haridis; Timothy Ambrose; Howard J Aizenstein; William Eddy; Oscar L Lopez; David A Wolk; Lauri Parkkonen; Anto Bagic
Journal:  J Neurosci Methods       Date:  2012-03-05       Impact factor: 2.390

3.  Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards.

Authors:  John R Crawford; Paul H Garthwaite; Sara Porter
Journal:  Cogn Neuropsychol       Date:  2010-10-09       Impact factor: 2.468

4.  Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.

Authors:  Lucette A Cysique; Bruce J Brew; Mark Halman; Jose Catalan; Ned Sacktor; Richard W Price; Steve Brown; J Hampton Atkinson; David B Clifford; David Simpson; Gabriel Torres; Colin Hall; Christopher Power; Karen Marder; Justin C McArthur; William Symonds; Carmen Romero
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

5.  Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Authors:  Samanta Simioni; Matthias Cavassini; Jean-Marie Annoni; Aline Rimbault Abraham; Isabelle Bourquin; Véronique Schiffer; Alexandra Calmy; Jean-Philippe Chave; Ezio Giacobini; Bernard Hirschel; Renaud A Du Pasquier
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

Review 6.  The Alzheimer's disease neuroimaging initiative.

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

7.  HIV-associated cognitive impairment before and after the advent of combination therapy.

Authors:  Ned Sacktor; Michael P McDermott; Karen Marder; Giovanni Schifitto; Ola A Selnes; Justin C McArthur; Yaakov Stern; Steve Albert; Donna Palumbo; Karl Kieburtz; Joy A De Marcaida; Bruce Cohen; Leon Epstein
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

8.  Functional connectivity measured with magnetoencephalography identifies persons with HIV disease.

Authors:  James T Becker; Ricardo Bajo; Melissa Fabrizio; Gustavo Sudre; Pablo Cuesta; Howard J Aizenstein; Oscar L Lopez; David Wolk; Lauri Parkkonen; Fernando Maestu; Anto Bagic
Journal:  Brain Imaging Behav       Date:  2012-09       Impact factor: 3.978

9.  Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.

Authors:  Steven Paul Woods; Julie D Rippeth; Alan B Frol; Joel K Levy; Elizabeth Ryan; Vicki M Soukup; Charles H Hinkin; Deborah Lazzaretto; Mariana Cherner; Thomas D Marcotte; Benjamin B Gelman; Susan Morgello; Elyse J Singer; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-09       Impact factor: 2.475

Review 10.  Biomarkers of HIV-1 CNS infection and injury.

Authors:  R W Price; L G Epstein; J T Becker; P Cinque; M Gisslen; L Pulliam; J C McArthur
Journal:  Neurology       Date:  2007-10-30       Impact factor: 9.910

View more
  7 in total

1.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

Review 2.  Neurologic Complications in Treated HIV-1 Infection.

Authors:  Nisha S Bhatia; Felicia C Chow
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

3.  Decreased MEG beta oscillations in HIV-infected older adults during the resting state.

Authors:  Katherine M Becker; Elizabeth Heinrichs-Graham; Howard S Fox; Kevin R Robertson; Uriel Sandkovsky; Jennifer O'Neill; Susan Swindells; Tony W Wilson
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

4.  Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease.

Authors:  Lindsay J Hines; Eric N Miller; Charles H Hinkin; Jeffery R Alger; Peter Barker; Karl Goodkin; Eileen M Martin; Victoria Maruca; Ann Ragin; Ned Sacktor; Joanne Sanders; Ola Selnes; James T Becker
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

5.  Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Authors:  Mikhail Popov; Samantha A Molsberry; Fabrizio Lecci; Brian Junker; Lawrence A Kingsley; Andrew Levine; Eileen Martin; Eric Miller; Cynthia A Munro; Ann Ragin; Eric Seaberg; Ned Sacktor; James T Becker
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

6.  Altered functional response to risky choice in HIV infection.

Authors:  Colm G Connolly; Amanda Bischoff-Grethe; Stephan J Jordan; Steven Paul Woods; Ronald J Ellis; Martin P Paulus; Igor Grant
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

7.  Neural dynamics of selective attention deficits in HIV-associated neurocognitive disorder.

Authors:  Brandon J Lew; Timothy J McDermott; Alex I Wiesman; Jennifer O'Neill; Mackenzie S Mills; Kevin R Robertson; Howard S Fox; Susan Swindells; Tony W Wilson
Journal:  Neurology       Date:  2018-10-17       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.